Evaluation of the Effects of a Novel Dietary Microalgae Based Ingredient on Muscle Recovery and Endurance Capacity
NCT ID: NCT05760742
Last Updated: 2023-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2023-01-10
2023-08-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Chlorella Supplementation on Health and Performance Following a 12-week Training Programme
NCT05639634
Spirulina Supplementation In Recovery From Damaging Exercise
NCT06391957
Effectiveness of Two Different Forms of Marine Oil on Indirect Markers of Muscle Damage and Soreness in Untrained Men
NCT03760757
The Effects of L-arginine Supplementation on Anaerobic Exercise Performance
NCT06475391
The Effects of a Novel Nutritional Product on Nutrient Status and Digestive Health
NCT06181214
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo group
2 capsules of Maltodextrin per day
Placebo
2 months of supplementation with a placebo (Maltodextrin)
MicAlgae100
2 capsules per day containing 100mg of microalgae based ingredient
MicAlgae
2 months of supplementation with an innovative microalgae based ingredient
MicAlgae250
2 capsules per day containing 250mg of microalgae based ingredient
MicAlgae
2 months of supplementation with an innovative microalgae based ingredient
MicAlgae500
2 capsules per day containing 500mg of microalgae based ingredient
MicAlgae
2 months of supplementation with an innovative microalgae based ingredient
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MicAlgae
2 months of supplementation with an innovative microalgae based ingredient
Placebo
2 months of supplementation with a placebo (Maltodextrin)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy as assessed by Medical and activity history questionnaire (MHQ)
* Recreationally active according to American College of Sports Medicine guidelines
* Able to provide written and dated informed consent to participate in the study
Exclusion Criteria
* Any response of "yes" on the PAR-Q+
* Physical limitations preventing running, countermovement jump, and strength (peak isometric torque and peak isokinetic torque) assessments
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Central Florida
OTHER
Microphyt
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Fukuda, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Central Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Central Florida
Orlando, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00004940
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.